Daré Bioscience, Inc. (DARE)
0.689
-0.02
(-2.41%)
USD |
NASDAQ |
Oct 20, 16:00
0.685
0.00 (0.00%)
After-Hours: 20:00
Daré Bioscience Gross Profit (TTM) : -1.748M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.748M |
| March 31, 2026 | -1.805M |
| December 31, 2025 | -1.417M |
| September 30, 2025 | -1.444M |
| June 30, 2025 | -0.8263M |
| March 31, 2025 | -0.2191M |
| September 30, 2024 | 1.835M |
| June 30, 2024 | 2.794M |
| March 31, 2024 | 2.778M |
| December 31, 2023 | 2.775M |
| September 30, 2023 | 0.9728M |
| June 30, 2023 | -0.021M |
| March 31, 2023 | 9.983M |
| December 31, 2022 | 9.982M |
| September 30, 2022 | 9.91M |
| June 30, 2022 | 9.931M |
| March 31, 2022 | -0.0705M |
| December 31, 2021 | -0.0717M |
| September 30, 2021 | -0.0021M |
| June 30, 2021 | -0.0323M |
| March 31, 2021 | -0.0377M |
| December 31, 2020 | -0.0432M |
| September 30, 2020 | -0.0441M |
| June 30, 2020 | -0.0328M |
| March 31, 2020 | -0.0219M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0111M |
| September 30, 2019 | -0.0047M |
| June 30, 2019 | -0.0045M |
| March 31, 2019 | -0.0036M |
| December 31, 2018 | -0.0024M |
| September 30, 2018 | -0.0013M |
| June 30, 2018 | -0.0003M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.068M |
| March 31, 2017 | -0.134M |
| December 31, 2016 | -0.195M |
| September 30, 2016 | -0.258M |
| June 30, 2016 | -0.236M |
| March 31, 2016 | -0.212M |
| December 31, 2015 | -0.192M |
| September 30, 2015 | -0.162M |
| June 30, 2015 | -0.146M |
| March 31, 2015 | -0.104M |
| December 31, 2014 | -0.063M |
| September 30, 2014 | -0.058M |
| June 30, 2014 | -0.028M |
| March 31, 2014 | -0.109M |
| December 31, 2013 | -0.109M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Elite Pharmaceuticals, Inc. | 59.79M |
| Eton Pharmaceuticals, Inc. | 61.10M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Veru, Inc. | -0.113M |